AI is transforming presentations. These AI tools for ppt creation will help you keep up with the times and take your ppts to the next level.

Roche's oral BTK inhibitor fenebrutinib has hit the spot in the final trial in its phase 3 programme, in relapsing multiple sclerosis (RMS), and is now being prepared for regulatory filings. The ...

As PCMag's resident data journalist, I practically live in Microsoft Excel. I've learned that it's capable of far more than I ...